Saturn V Capital Management as of Sept. 30, 2024
Portfolio Holdings for Saturn V Capital Management
Saturn V Capital Management holds 25 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 10.7 | $30M | 200k | 149.31 | |
| Disc Medicine (IRON) | 9.0 | $25M | 511k | 49.14 | |
| Vaxcyte (PCVX) | 8.4 | $23M | 205k | 114.27 | |
| Cg Oncology (CGON) | 7.0 | $20M | 520k | 37.73 | |
| Cogent Biosciences (COGT) | 6.6 | $19M | 1.7M | 10.80 | |
| Cargo Therapeutics (CRGX) | 6.6 | $19M | 1.0M | 18.45 | |
| Cytokinetics Com New (CYTK) | 6.3 | $18M | 331k | 52.80 | |
| Phathom Pharmaceuticals (PHAT) | 5.7 | $16M | 875k | 18.08 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 5.4 | $15M | 299k | 50.42 | |
| Celcuity (CELC) | 5.0 | $14M | 946k | 14.91 | |
| Argenx Se Sponsored Adr (ARGX) | 4.3 | $12M | 22k | 542.08 | |
| Syndax Pharmaceuticals (SNDX) | 3.5 | $9.7M | 502k | 19.25 | |
| Silence Therapeutics Ads (SLN) | 3.1 | $8.7M | 481k | 18.18 | |
| Abivax Sa Sponsored Ads (ABVX) | 2.7 | $7.5M | 648k | 11.52 | |
| Inozyme Pharma (INZY) | 2.6 | $7.2M | 1.4M | 5.23 | |
| Merus N V (MRUS) | 2.3 | $6.6M | 131k | 49.96 | |
| Kalvista Pharmaceuticals (KALV) | 2.3 | $6.4M | 557k | 11.58 | |
| Neumora Therapeutics (NMRA) | 2.0 | $5.7M | 433k | 13.21 | |
| Crinetics Pharmaceuticals In (CRNX) | 2.0 | $5.6M | 110k | 51.10 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 1.6 | $4.6M | 1.1M | 4.12 | |
| BioMarin Pharmaceutical (BMRN) | 0.9 | $2.6M | 37k | 70.29 | |
| Iteos Therapeutics | 0.7 | $2.0M | 196k | 10.21 | |
| Contineum Therapeutics Cl A (CTNM) | 0.5 | $1.5M | 77k | 19.14 | |
| Arrivent Biopharma (AVBP) | 0.4 | $1.1M | 47k | 23.50 | |
| Longboard Pharmaceuticals In | 0.4 | $1.1M | 32k | 33.33 |
